An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A new report says that people taking semaglutide — the drug in Ozempic and Wegovy — often find that their initial loss of hunger eases over time. In other words, the strong, early drop in appetite that many users notice doesn't always stay the same; feelings of hunger can creep back even while people keep losing weight or staying on the medicine. Semaglutide is a man-made version of a natural gut hormone that talks to the brain about food and fullness. It slows how fast your stomach empties and makes you feel fuller after smaller meals. Doctors use it for diabetes and for weight management. Lots of headlines have described it as a medicine that sharply cuts appetite, and that's true for many people at first. The new piece reports that the appetite-reducing effect isn’t always permanent. Over weeks to months, some users say they start feeling hungrier than they did right after starting treatment. The write-up appears to summarize clinical observations and patient reports rather than announcing a single big trial proving a predictable timeline. That means the evidence is real but mixed: some people keep low appetite for a long time, others see only a temporary dip. The story doesn’t claim everyone will regain previous hunger levels or exactly when that will happen. This matters because many people use semaglutide to help change eating habits and lose weight. If hunger comes back, they may need extra support: behavior strategies, nutrition coaching, or adjusted dosing from their doctor. It also affects expectations — knowing that hunger can return helps people plan for long-term maintenance instead of assuming the drug is a complete, permanent fix. There are important caveats. Semaglutide is a prescription medication with side effects like nausea, diarrhea, or rare but serious risks; it’s not a candy. The degree and timing of hunger returning likely vary by person, dose, and other health factors. This report doesn’t mean the drug is ineffective — it just highlights that appetite control can be dynamic. Anyone considering semaglutide should discuss benefits and risks with their clinician and not rely on headlines alone. Bottom line: semaglutide often cuts appetite at first, but for many people that reduced hunger can lessen over time, so plan for ongoing support and medical guidance.
Source: Psychiatry Advisor